Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
PubMed Full text in PMC Similar studies
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma
PubMed Similar studies Analyze with GEO2RSRA Run Selector
Gene expression profile of hepatocellular carcinomain in Taiwan
Gene expression profile of hepatocellular carcinomain in Taiwan (subset 2)
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Gene expression profile of hepatocellular carcinomain in Taiwan (subset 1)
Tumor immune microenvironment difference primary and metastatic hepatocellular carcinoma
PubMed Full text in PMC Similar studies Analyze with GEO2R
Exploration of exhausted CD8 T cell markers to predict response to immune checkpoint inhibitor therapy for hepatocellular carcinoma
Comprehensive testing of chemotherapy and immune checkpoint blockade in preclinical cancer models identifies additive combinations
PubMed Full text in PMC Similar studies SRA Run Selector
Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV- HNSCC
PubMed Similar studies
Transcriptomic analysis of ChAdOx/MVA P1A vaccine-induced P1A-35-43-specific CD8+ T-cells by single-cell RNA-sequencing
Transcriptomic analysis of 15V4T3 tumours from ChAd/MVA vaccine + anti-PD-1 treated mice by RNA-sequencing
Intratumoral mregDC and Tfh-like niches enable local reinvigoration of CD8 T cells following PD-1 blockade
RNA N6-methyladenosine methyltransferase METTL3 drives NAFLD-HCC and is a therapeutic target for boosting immunotherapy
RNA N6-methyladenosine methyltransferase METTL3 drives NAFLD-HCC and is a therapeutic target for boosting immunotherapy [m6A-seq]
RNA N6-methyladenosine methyltransferase METTL3 drives NAFLD-HCC and is a therapeutic target for boosting immunotherapy [RNA-Seq]
Unbiased functional identification and therapeutic targeting of T cell neoantigens in a spontaneous murine squamous cell carcinoma
Unbiased functional identification and therapeutic targeting of T cell neoantigens in a spontaneous murine squamous cell carcinoma [Single cell]
Unbiased functional identification and therapeutic targeting of T cell neoantigens in a spontaneous murine squamous cell carcinoma [Bulk-seq]
IMMUNE CORRELATES OF RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN ACUTE MYELOID LEUKAEMIA
IMMUNE SENESCENCE PHENOTYPES PREDICT CHEMOTHERAPY RESISTANCE IN ACUTE MYELOID LEUKAEMIA
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on